Abstract
The concept of screening is that detection of early disease may permit treatment at a more tractable stage and thus improve prospects for survival and prevention of death from the disease (Morrison 1992). In technical terms, it is the periodical routine examination of the general population or large subgroups of it for early asymptomatic disease by application of dedicated screening tests (UICC 1978; Miller 1985).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abel U (1993) Die Bewertung diagnostischer Tests. Hippokrates Verlag Stuttgart
Auvinen A, Alexander FE, de Koning HJ, Miller AB (2002) Should we start population screening for prostate cancer? Randomised trials are still needed. Int J Cancer 97:377–378
Bartsch G, Horninger W, Klocker H, Reissigl A, Oberaigner W, Schönitzer D, Severi G, Robertson C, Boyle P (2001) Prostate cancer mortality after introduction of prostatespecific antigen mass screening in the Federal State of Tyrol, Austria. Urology 58:417–424
Cebul RD, Hershey JC, Williams SV (1982) Using multiple tests: series and parallel approaches. Clin Labor Med 2:871–890
Hoffrage U, Lindsey S, Hertwig R, Gigerenzer G (2000) Communicating statistical information. Science 290:2261–2265
IARC (2005) Cervix cancer screening. IARC handbooks of cancer prevention. International Agency for Research on Cancer, World Health Organization. IARC Press, Lyon
Jung H (2001) Estimate of benefits versus radiation risks from mammographic screening. Der Radiologe 41:385–395
Lin SCC (1999) Some Results on Combinations of two Binary Screening Tests. Journal of Biopharmaceutical Statistics 9:81–88
McIntosh MW, Pepe MS (2002) Combining Several Screening Tests: Optimality of the Risk Score. Biometrics 58:657–664
Miller AB (ed.) (1985) Screening for cancer. Academic Press, Toronto Montreal
Morrison AS (1992) Screening in Chronic Disease. Monographs in Epidemiology and Biostatistics Volume 19. Oxford University Press, New York Oxford
Moss SM and UK Trial of Early Detection of Breast Cancer Group (1999) 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet 353:1909–1914
Paley PJ (2001) Ovarian cancer screening: are we making any progress?. Curr Opin Oncol 13:399–402
Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, Puthaar E (eds.) (2006) European guidelines for quality assurance in breast cancer screening and diagnosis — fourth edition. Office for Official Publications of the European Communities, Luxembourg
Prorok PC (1995) Screening studies. In: Greenwald P, Kramer BS, Weed DL. Cancer Prevention and Control. Marcel Dekker, New York Basel Hon Kong 1995, pp 225–242
Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J (2002) Neuroblastoma screening at one year of age. N Engl J Med 346:1047–1053
Union Internationale Contre le Cancer (UICC) (1978) Clinical Oncology. Springer, Berlin Heidelberg New York
Walter SD, Day NE (1983) Estimation of the Duration of a Pre-Clincal Disease State using Screening Data. Am J Epidemiol 118:865–886
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Becker, N. (2008). Epidemiology and Statistics. In: Reiser, M.F., van Kaick, G., Fink, C., Schoenberg, S.O. (eds) Screening and Preventive Diagnosis with Radiological Imaging. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-49831-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-540-49831-5_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23553-8
Online ISBN: 978-3-540-49831-5
eBook Packages: MedicineMedicine (R0)